4D Molecular Therapeutics, Inc.
NASDAQ:FDMT · NASDAQ Global Select
+$0.16 today
Vol 0.65M · Avg 0.77M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+156.23%
Period High
$12.27
Period Low
$3.71
Latest
$9.66
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
$1.44B
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$890.92M
Omeros Corporation
NASDAQ:OMER
$740.40M
Prothena Corporation plc
NASDAQ:PRTA
$460.45M
REGENXBIO Inc.
NASDAQ:RGNX
$417.02M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$281.41M
Bicycle Therapeutics plc
NASDAQ:BCYC
$277.58M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$271.66M
ADC Therapeutics S.A.
NYSE:ADCT
$138.00M
Gossamer Bio, Inc.
GOSS
$39.26M
What is the latest FDMT filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does FDMT have?
Intrinsic Alpha currently shows 20 recent filings for FDMT.
Explore More
Continue the stock analysis
Jump to another research area for this company.